118 related articles for article (PubMed ID: 35381056)
1. Binding affinity and conformation of a conjugated AS1411 aptamer at a cationic lipid bilayer interface.
Li P; Wang L; Sun M; Yao J; Li W; Lu W; Zhou Y; Zhang G; Hu C; Zheng W; Wei F
Phys Chem Chem Phys; 2022 Apr; 24(15):9018-9028. PubMed ID: 35381056
[TBL] [Abstract][Full Text] [Related]
2. Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.
Riccardi C; Musumeci D; Russo Krauss I; Piccolo M; Irace C; Paduano L; Montesarchio D
Int J Biol Macromol; 2018 Oct; 118(Pt B):1384-1399. PubMed ID: 30170359
[TBL] [Abstract][Full Text] [Related]
3. Stern-Layer Adsorption of Oligonucleotides on Lamellar Cationic Lipid Bilayer Investigated by Polarization-Resolved SFG-VS.
Wang L; Shen Y; Yang Y; Lu W; Li W; Wei F; Zheng G; Zhou Y; Zheng W; Cao Y
ACS Omega; 2017 Dec; 2(12):9241-9249. PubMed ID: 30023605
[TBL] [Abstract][Full Text] [Related]
4. High affinity of AS1411 toward copper; its application in a sensitive aptasensor for copper detection.
Bahreyni A; Ramezani M; Alibolandi M; Hassanzadeh P; Abnous K; Taghdisi SM
Anal Biochem; 2019 Jun; 575():1-9. PubMed ID: 30926271
[TBL] [Abstract][Full Text] [Related]
5. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
6. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
8. The electric double layer structure modulates poly-dT
Li P; Shen Y; Wang L; Lu W; Li W; Chen K; Zhou Y; Shen L; Wei F; Zheng W
Soft Matter; 2019 Jun; 15(22):4445-4453. PubMed ID: 31011740
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of delivering aptamer targeted nano-drugs into cells.
Liu Y; Yang Y; Zhang Q; Lu D; Li S; Li J; Yang G; Shan Y
J Mater Chem B; 2021 Jan; 9(4):952-957. PubMed ID: 33437980
[TBL] [Abstract][Full Text] [Related]
10. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
11. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
[TBL] [Abstract][Full Text] [Related]
12. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
[TBL] [Abstract][Full Text] [Related]
13. Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets.
Murphy EM; Centner CS; Bates PJ; Malik MT; Kopechek JA
PLoS One; 2020; 15(5):e0233466. PubMed ID: 32437399
[TBL] [Abstract][Full Text] [Related]
14. Progress in cancer drug delivery based on AS1411 oriented nanomaterials.
Tong X; Ga L; Ai J; Wang Y
J Nanobiotechnology; 2022 Jan; 20(1):57. PubMed ID: 35101048
[TBL] [Abstract][Full Text] [Related]
15. Bioactivity of 2'-deoxyinosine-incorporated aptamer AS1411.
Fan X; Sun L; Wu Y; Zhang L; Yang Z
Sci Rep; 2016 May; 6():25799. PubMed ID: 27194215
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.
Mehrnia SS; Hashemi B; Mowla SJ; Nikkhah M; Arbabi A
Radiat Oncol; 2021 Feb; 16(1):33. PubMed ID: 33568174
[TBL] [Abstract][Full Text] [Related]
17. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.
Lee KY; Kang H; Ryu SH; Lee DS; Lee JH; Kim S
J Biomed Biotechnol; 2010; 2010():168306. PubMed ID: 20204158
[TBL] [Abstract][Full Text] [Related]
18. A novel multifunctional nanoparticles formed by molecular recognition between AS1411 aptamer and redox-responsive paclitaxel-nucleoside analogue prodrug for combination treatment of β-lapachone and paclitaxel.
Chen X; Ji J; Zhou K; Fan X; Li L; Xu W
Colloids Surf B Biointerfaces; 2022 Apr; 212():112345. PubMed ID: 35074639
[TBL] [Abstract][Full Text] [Related]
19. Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives.
Ogloblina AM; Iaccarino N; Capasso D; Di Gaetano S; Garzarella EU; Dolinnaya NG; Yakubovskaya MG; Pagano B; Amato J; Randazzo A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096752
[TBL] [Abstract][Full Text] [Related]
20. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
